JBIO · Jade Biosciences, Inc. · Fails to Deliver
$15.13
+0.27 (+1.82%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$962.23M
Shares
63.60M
Volume · Oct 21
932.74K
Avg daily vol (3M)
902.38K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 838 | $14.18 | $11,883 |
| 2026-09-28 | 3,244 | $14.42 | $46,778 |
| 2026-09-25 | 3,473 | $14.73 | $51,157 |
| 2026-09-23 | 1,364 | $16.76 | $22,861 |
| 2026-09-18 | 3,535 | $17.14 | $60,590 |
| 2026-08-03 | 49,666 | $19.75 | $980,904 |
Showing 1–6 of 6 settlements
Key facts
CIK
1798749
CUSIP
008064206
13F (30d)
11 filings
11 filers
Visit website
Investor relations